Reaching Rural: Advancing Collaborative Solutions Opportunity Available

The Bureau of Justice Assistance (BJA), Centers for Disease Control and Prevention (CDC), National Association of Counties, and State Justice Institute (SJI) are co-sponsoring the Reaching Rural: Advancing Collaborative Solutions initiative. BJA, CDC, and SJI are supporting this initiative as part of an ongoing interagency partnership to strengthen public safety and public health collaboration under BJA’s Comprehensive Opioid, Stimulant, and Substance Abuse Program.
Posted Date

Global Review of Drug Checking Services Operating in 2017

Drug checking services invite members of the public to anonymously submit psychoactive drug samples for forensic analysis and then provide individualised feedback of results and counselling as appropriate. These services are known under many names, including: drug checking (services), street drug analysis, pill testing, adulterant screening, multi-agency safety testing, and drug safety testing. Here, we use the term ‘drug checking services’, while acknowledging that a lack of agreement about terminology persists.
Posted Date

TIP 33: Treatment for Stimulant Use Disorders

This updated TIP reviews what is known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and methamphetamine, as well as the misuse of prescription stimulants. The TIP offers recommendations on treatment approaches and maximizing treatment engagement and retention, and strategies for initiating and maintaining abstinence.
Posted Date

Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007–2019

In the United States, combined stimulant/opioid overdose mortality has risen dramatically over the last decade. These increases may particularly affect non-Hispanic Black and Hispanic populations. We used death certificate data from the US National Center for Health Statistics (2007–2019) to compare state-level trends in overdose mortality due to opioids in combination with 1) cocaine and 2) methamphetamine and other stimulants (MOS) across racial/ethnic groups (non-Hispanic White, non-Hispanic Black, Hispanic, and non-Hispanic Asian American/Pacific Islander).
Posted Date

RCORP Grantee Data Collection Resources (Psychostimulant Cohort)

HRSA and JBS have developed guidance to assist your RCORP data collection and Performance Improvement Measurement System (PIMS) reporting efforts. These measures are pending OMB clearance and are subject to revision. This page contains the RCORP data collection resources for the Psychostimulant Support grantees only. These documents will be updated as new guidance or data sources are identified. We encourage you to bookmark this page so you have the latest version available. Please send any measure-related questions to your HRSA Project Officer or email:
Posted Date

RCORP-Psychostimulant Support (RCORP-PS) Guidance Modules (B)

We are pleased to announce RCORP-Psychostimulant Support (RCORP-PS) guidance modules are now available. Module B – Program Implementation Guidance for Treatment and Recovery Core Activities shares information regarding the three required treatment and recovery core activities grantees will put into practice. You can access them below.

Posted Date

RCORP-Psychostimulant Support (RCORP-PS) Guidance Modules (A)

We are pleased to announce RCORP-Psychostimulant Support (RCORP-PS) guidance modules are now available. Module A – Program Implementation Guidance for Prevention Core Activities provides grantees with information about how to implement the three required prevention core activities. You can access them below.

Posted Date